RTW Investments reports $6 million acquisition of Orchestra BioMed common shares
OBIO•RTW Investments and Roderick Wong reported purchasing 1.2 million Orchestra BioMed shares at $5 each, bringing their reported indirect beneficial ownership to 10,756,063 shares.
1. Reported share purchase
RTW Investments and its managing partner, Roderick Wong, reported purchasing 1.2 million shares of Orchestra BioMed Holdings common stock at $5 per share. The transaction brought their reported indirect beneficial ownership to 10,756,063 shares; both are listed as 10% owners.
